Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol., 09 January 2026

Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1774415

Correction: New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosis

This article is a correction to:

  1. New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosis

    1. Read original article
Frontiers Production Office* Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

A Correction on
New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosis

By Rodero-Romero A, Domínguez-Mozo M, Monreal E, García-Domínguez JM, Villarrubia N, Fernández-Velasco JI, Comabella M, de la Maza SS, Goicochea Briceño H, Chico-García JL, García-Martínez MÁ, Rodriguez-Jorge F, Veiga-Gonzalez JL, Sainz-Amo R, Martínez Ginés ML, Montalban X, Masjuan J, Costa-Frossard L, Álvarez-Lafuente R and Villar LM (2025) Front. Immunol. 16:1729500. doi: 10.3389/fimmu.2025.1729500

The affiliation “Independent, Medellin, Columbia” for reviewer Ana Londono was erroneously given as “Independent, Cocos Islands”.

The original version of this article has been updated.

Keywords: multiple sclerosis, serum biomarkers, serum proteomics, neuroimmunology, demyelinated diseases

Citation: Frontiers Production Office (2026) Correction: New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosis. Front. Immunol. 16:1774415. doi: 10.3389/fimmu.2025.1774415

Received: 23 December 2025; Accepted: 23 December 2025;
Published: 09 January 2026.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2026 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.